Justin Leader founder and CEO of BenefitsDNA arrived in the benefits industry by the scenic route: medical school preparation, a master’s degree in exercise science, selling blood pressure medication at a pharmaceutical company, and then a detour into stockbroking at Morgan Stanley. At the pharmaceutical company he felt like “a glorified caterer running around to doctors’ offices.” At Morgan Stanley, building a book of business proved “frankly boring.”
A well connected independent broker owner eventually changed the trajectory, offering not a client relationship but a mentorship: “Kid, I’m not going to give you my money, but I’d love to give you an opportunity. I know that you have that will to win attitude.”
Leader joined Special Risk Insurance Services, a boutique agency consulting Fortune 500 companies including GlaxoSmithKline, Aramark, and IKEA Corporation, learning the industry from the top down rather than the usual path. In 2014, he founded BenefitsDNA with a clear mission: advice given “absent of conflict” and to “a higher ethical standard.” In the U.S. benefits industry, that turned out to be a revolutionary position.
The 160 million Americans who look to their employers for health insurance are, in most cases, receiving advice from advisors paid predominantly by the vendors in the marketplace they are supposed to scrutinize. Leader does not soften it: “If I’m working for the vendors as opposed to the people I’m meant to serve, there’s inherent conflict there.”
Most of the industry has been built on receiving indirect and undisclosed compensation from those same vendors. The result is a system that works, Leader says, “not in the aspect of delivering high value care, but more so in the ability to extract dollars.” Hidden prices, shrouded competition, and advisors operating in the shadows of the vendors they are meant to challenge have created a structure that consistently fails the people at its center.
The cost falls on real families. “It comes on the back of the U.S. employer and every single family that is contributing to these health insurance plans.” The consequence is stark: “It’s become an existential crisis for most Americans.” More than half of all GoFundMe campaigns are now created to pay for medical debt.
Will transparency legislation actually deliver change? And will the industry simply find ways around the new rules? Leader’s answer to both questions is the same: “Yes and yes.” The rules exist. The enforcement, largely, does not. Florida is suing Express Scripts and Prime Therapeutics. Major brokerage houses face lawsuits over undisclosed compensation, uncovered not through voluntary disclosure but through legal discovery. Leader is not watching from the sidelines. “I’ve talked with the Department of Labor. I’m on a text basis with one of the policy writers down there regarding a lot of the things that we see in practice, which are frustrating and in any other industry would be illegal.”
Meanwhile, “50% of my business now is purely through people coming and wanting to uncover the truth.” He invokes Ted Lasso: “The truth will set you free, but first it’ll piss you off.” That reaction, he says, is increasingly common among plan sponsors who discover just how much has been extracted on their watch.
Change is coming, but at three speeds. “Slow, turtle, and glacial.”
Two years ago, Leader drew a comparison between U.S. healthcare and the housing bubble that triggered the 2009 financial crisis. He stands by it today. “I think that bubble is bursting.” Seven figure claims are hitting plans. Premium increases are at their highest in 15 to 20 years. And the social temperature is rising in ways that are hard to ignore. Frustration with the healthcare system is, as Leader observes, “very bipartisan.” Nobody on either side of the aisle disagrees that it is broken. Agreeing on how to fix it is another matter entirely.
What is not in question is the depth of the anger. The murder of the CEO of UnitedHealthcare in public, and the quiet understanding it drew from large sections of the American public, was for Leader a deeply uncomfortable but telling signal. “There’s such distrust and lack of sympathy regarding this system that is consuming people.” That frustration is not, he insists, aimless. It is an indicator of a bubble about to burst.
The trend that troubles Leader most is older and far more widespread than any single drug or treatment: cost shifting. When plans come under pressure, the reflex is to increase deductibles, copays, and coinsurance, passing the burden directly to employees. “It shouldn’t be the first choice.”
The numbers are stark. More than 70% of U.S. households have less than $1,000 in their checking accounts. The average deductible is roughly $2,000. The ALICE demographic (asset limited, income constrained, yet employed) bears the sharpest pain. These workers gravitate toward high deductible health plans because the premiums are lower, only to face bills they cannot absorb. “That can be catastrophic for a family that’s living paycheck to paycheck.” It is not a benefits strategy. It is a financial time bomb.
Warren Buffett once called the U.S. healthcare system “a tapeworm for employers.” Every company employing more than 50 full time people is legally required to offer a health plan or face penalties under the ACA. Whether they like it or not, they are also healthcare companies. Leader’s message to the C suite is unambiguous.
The annual renewal meeting is no longer sufficient. Every health plan has four core components regardless of how it is funded: the PBM, the administrator, the stop loss or insurance arrangement, and the network. While the BUCAs (the Blues, United, Cigna, and Aetna) dominate the national group health insurance market, most employers are unaware that independent third party administrators for claims adjudication, independent PBMs, and alternative stop loss structures exist as genuine alternatives.
Each component must be evaluated as a standalone expense, benchmarked against the market, and scrutinized against the fiduciary standards set out in the Consolidated Appropriations Act 2021 through 2026. “You have to have somebody monitoring what’s going on within the plan, and that is no longer a negotiable.” Without it, a plan sponsor is not merely being incautious. They are in breach of their duty of prudence and loyalty.
For employers who want to step away from traditional group coverage entirely, the ICHRA (Individual Coverage HRA) offers a defined contribution alternative that Leader considers viable for at least the next two years. Whether it holds up beyond that, given the volatility in the individual marketplace and expiring subsidies, is, as he puts it, “another conversation to be had.”
Monitoring a plan in real time is no longer optional. BenefitsDNA has built out technology feeds to ingest claims data, run budget analysis reporting, and diagnose areas of opportunity throughout the plan year, not just at renewal. But Leader is clear about the limits of what any firm can predict. “There are things that are unpreventable that will occur within a health plan.” A car accident. A cancer diagnosis. An e-bike incident (a trend, he notes drily, he would very much like to see go away). The question is not just whether a high cost claimant can be identified, but what can ethically and legally be done once they are.
“We need to be very cognizant of discrimination rules,” he says. HIPAA compliance is not a formality. “We want to make sure that we’re not cutting somebody’s access to care.” Some advisors, he acknowledges, do exactly that. “It’s a means to an end, but we also have to really understand what you’re doing to that individual’s family and whether you’re opening up a liability risk.”
For ongoing high cost claimants, the math can overwhelm even a well run plan. “I don’t know a plan with a few hundred employees, or 80 employees, that can withstand a $2 million a year claimant.” Stop loss insurers in those situations will either decline to quote or exclude that individual from coverage entirely. “That’s where we need to wave the white flag to the federal government and say, we need some sort of support for this employer system.”
Leader’s own sector is in the midst of profound change. The consolidation sweeping the industry (Aon’s $17 billion acquisition of USI being the most recent example) is opening space for nimbler, independently owned firms to operate differently and offer something the large houses cannot. Leader and a generation of peers are determined to seize it.
That challenge extends across a benefits landscape far broader than most employers recognize. It is, he notes, uniquely American that “eyeballs and teeth don’t fall into the primary health plan.” Dental and vision sit in a separate bucket entirely. So do the paycheck protections: life, disability, and accident insurance, the benefits that support families “in dire times, whether it be disability or death.” Independent firms are better placed than large consolidated houses to look across all of it and ask which pieces need rethinking.
The reach of that work can be extraordinary. “Our customers are anywhere from a 20 employee youth ballet to a 35,000 life teachers union.” That breadth is a privilege, Leader says, and it is why the business has invested heavily in both people and technology. AI will play a growing role, but not as a replacement for human judgment. What it offers is efficiency on the things that do not require a human, freeing advisors to focus on the work that does. The number one thing new clients tell BenefitsDNA: “We no longer trusted our advisor. We trust you.”
He co-hosts the EOB podcast (Explanation of Benefits) using plain language, humor, and even puppets to explain a system most Americans find impenetrable. He maintains a daily text thread with seven independent agency owners across the country, a group he has been in contact with for eight years. “I wouldn’t be where I’m at today if it wasn’t for having those other people to lean on and share experiences with.” The business, he acknowledges, is “one of constant crisis followed by blips of intense success.”
He was raised in rural Pennsylvania by his grandfather and great grandmother, the first in his family to attend college. It is that origin that shapes everything. “The one thing I love more than anything on this planet, the one thing I grew up without, my father.” Being present for his two boys is, he says, an immense source of joy. He works out. He loves music. “I’ll be a rocker and punk rocker till the day I die.”
There is no villain in the story he tells. “There’s no boogeyman. There are a lot of great people that work at these various institutions. We’ve just constructed a very good system built on opacity and the ability to extract dollars while convincing the American public that we are the best in the world.” While he sees that as an accurate description of the current state of healthcare, he does not believe it has to remain that way. He believes it can change. After nearly two decades fighting for reform, that conviction is perhaps the most disruptive thing about him.
